Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 28 Total
SPLK - Splunk Inc. - Stock Price Chart
CompanySplunk Inc.
IndustrySoftware - Infrastructure
Market Cap24.49BEPS (ttm)-0.13
P/E-EPS this Y79.30%
Forward P/E32.93EPS next Y14.88%
PEG-EPS past 5Y-4.70%
P/S6.37EPS next 5Y25.10%
P/B-EPS Q/Q70.70%
Dividend-Sales Q/Q14.00%
Insider Own0.30%Inst Own88.20%
Insider Trans-9.25%Inst Trans1.67%
Short Float3.47%EarningsAug 23/a
Analyst Recom2.10Target Price127.44
Avg Volume1.55M52W Range65.00 - 125.91
Splunk Inc., together with its subsidiaries, develops and markets cloud services and licensed software solutions in the United States and internationally. The company offers unified security and observability platform, including Splunk Security that helps security leaders fortify their organization's digital resilience by mitigating cyber risk and meeting compliance requirements; and Splunk Observability, which provides visibility across the full stack of infrastructure, applications, and the digital customer experience. It also provides application programming interfaces, software development kits, and other interfaces that enables its network of third-party developers, partners, and customers to build content, including pre-built data inputs, workflows, searches, reports, alerts, custom dashboards, flexible user interface components, custom data visualizations, and integration actions and methods that configures and extends its solutions to accommodate specific use cases. In addition, the company offers adoption and implementation, education, and customer support services. It sells its offerings directly through field and inside sales, and indirectly through various routes to market with various partners. Splunk Inc. was incorporated in 2003 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Steele GaryPresident and CEOSep 18Sale120.089,6001,152,768154,678Sep 20 04:08 PM
Steele ElisaDirectorAug 30Sale120.002,812337,44011,108Sep 01 04:10 PM
Steele ElisaDirectorAug 24Sale112.003,050341,60013,920Aug 28 04:10 PM
Morgan ScottSVP, CLO, Global Affairs & SecJul 10Sale104.194,996520,545122,889Jul 11 04:11 PM
Steele GaryPresident and CEOJul 07Sale104.479,6001,002,868167,254Jul 11 04:09 PM
TRT - Trio-Tech International - Stock Price Chart
TickerTRT [AMEX]
CompanyTrio-Tech International
IndustrySemiconductor Equipment & Materials
Market Cap29.82MEPS (ttm)0.52
P/E13.68EPS this Y483.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y9.60%
P/S0.65EPS next 5Y-
P/B0.96EPS Q/Q93.00%
Dividend-Sales Q/Q-11.70%
Insider Own4.40%Inst Own15.40%
Insider Trans-10.85%Inst Trans-34.79%
Short Float0.56%Earnings-
Analyst Recom-Target Price-
Avg Volume12.82K52W Range4.05 - 6.98
Trio-Tech International, together with its subsidiaries, offers manufacturing, testing, and distribution services to the semiconductor industry. It operates through four segments: Manufacturing, Testing Services, Distribution, and Real Estate. The company's Testing Services segment offers stabilization bake, thermal shock, temperature cycling, mechanical shock, constant acceleration, gross and fine leak, electrical, static and dynamic burn-in, and vibration testing, as well as reliability lab and microprocessor equipment contract cleaning services. This segment also provides qualification testing services that test small samples of output from manufacturers for qualification of their processes and devices. The Manufacturing segment manufactures front-end semiconductor test equipment, such as artic temperature-controlled wafer chucks used for test, characterization, and failure analysis of semiconductor wafers and other components; and wet process stations for cleaning, rinsing, and drying semiconductor wafers, flat panel display magnetic disks, and other microelectronic substrates. This segment also manufactures back-end products comprising autoclaves and highly accelerated stress test equipment; burn-in equipment and boards; and component centrifuges and leak detection equipment. The company's Distribution segment distributes complementary products, including environmental chambers, handlers, interface systems, vibration systems, shaker systems, solderability testers, and other semiconductor equipment, as well as components, such as connectors, sockets, LCD display panels, and touch-screen panels. Its Real Estate segment invests in and rents real estate properties. The company primarily serves semiconductor chip manufacturers or testing facilities that purchase testing equipment. It operates in the United States, Singapore, Malaysia, Thailand, and China. The company was incorporated in 1958 and is headquartered in Van Nuys, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ADELMAN JASON TDirectorJun 07Sale4.842,0009,68010,000Jun 07 06:46 PM
ADELMAN JASON TDirectorJun 02Sale4.822,0009,64012,000Jun 07 06:46 PM
ADELMAN JASON TDirectorJun 01Sale5.002,00010,00014,000Jun 07 06:46 PM
ADELMAN JASON TDirectorMay 30Sale4.882,0009,76016,000Jun 07 06:46 PM
ADELMAN JASON TDirectorMay 26Sale4.652,0009,30018,000Jun 07 06:46 PM
IMMX - Immix Biopharma, Inc. - Stock Price Chart
CompanyImmix Biopharma, Inc.
Market Cap53.51MEPS (ttm)-0.80
P/E-EPS this Y82.50%
Forward P/E-EPS next Y-4.70%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.92EPS Q/Q-111.20%
Dividend-Sales Q/Q-
Insider Own13.60%Inst Own2.20%
Insider Trans7.38%Inst Trans39.15%
Short Float2.51%Earnings-
Analyst Recom2.00Target Price11.00
Avg Volume132.46K52W Range0.68 - 3.40
Today 08:55AM U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis (GlobeNewswire) +15.38%
Sep-19-23 09:10AM Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site (GlobeNewswire) +24.15%
Sep-15-23 01:18PM Director Helen Adams Buys 13,000 Shares of Immix Biopharma Inc (IMMX) ( +5.12%
Sep-07-23 10:38AM The 3 Best Speculative Stocks to Buy Now: September 2023 (InvestorPlace)
08:41AM Nexcella, Immix Biopharma Subsidiary, to Present at the Bank of America 2023 Healthcare Trailblazers Private Company Conference (GlobeNewswire)
Sep-01-23 08:39AM Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board (GlobeNewswire) +12.81%
Aug-23-23 08:37AM U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Multiple Myeloma (GlobeNewswire) +11.11%
Aug-18-23 09:20AM Immix Biopharma Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board (GlobeNewswire) +6.13%
Aug-16-23 09:05AM Immix Biopharma Announces Additional NXC-201 AL Amyloidosis Clinical Data Accepted for Oral Presentation at the 20th International Myeloma Society Annual Meeting (September 27-30, Athens Greece) (GlobeNewswire)
Jul-25-23 08:42AM Immix Biopharma Subsidiary Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International Myeloma Society Annual Meeting (GlobeNewswire)
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hsu JasonDirectorSep 15Buy2.497,00017,396757,000Sep 18 07:03 PM
Hsu JasonDirectorSep 14Buy2.5810,00025,772750,000Sep 18 07:03 PM
Ng CareyDirectorSep 14Buy2.5810,00025,76010,000Sep 15 06:27 PM
Hsu JasonDirectorSep 12Buy2.8330,00084,864740,000Sep 18 07:03 PM
Adams Helen C.DirectorSep 12Buy2.9613,00038,49213,000Sep 14 05:20 PM
MTRX - Matrix Service Company - Stock Price Chart
CompanyMatrix Service Company
IndustryEngineering & Construction
Market Cap277.22MEPS (ttm)-1.94
P/E-EPS this Y18.70%
Forward P/E13.05EPS next Y181.82%
PEG-EPS past 5Y-34.10%
P/S0.35EPS next 5Y10.00%
P/B1.51EPS Q/Q-102.40%
Dividend-Sales Q/Q2.60%
Insider Own5.20%Inst Own83.50%
Insider Trans0.00%Inst Trans-2.01%
Short Float0.64%EarningsSep 11/a
Analyst Recom1.50Target Price14.50
Avg Volume100.54K52W Range3.31 - 9.81
Matrix Service Company provides engineering, fabrication, construction, and maintenance services to support critical energy infrastructure and industrial markets in the United States, Canada, and internationally. It operates through three segments: Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions. The Utility and Power Infrastructure segment offers power delivery services, including construction of new substations, upgrades of existing substations, transmission and distribution line installations, and upgrades and maintenance, and emergency and storm restoration services. This segment also provides engineering, fabrication, and construction services for LNG utility peak shaving facilities; and construction and maintenance services to power generation facilities, including natural gas fired facilities. The Process and Industrial Facilities segment engages in the refining and processing of crude oil; fractionating and marketing of natural, gas and natural gas liquids; and offers plant maintenance, turnarounds, engineering, industrial cleaning services, and capital construction services. The Storage and Terminal Solutions segment undertakes work related to aboveground crude oil and refined product storage tanks and terminals; engineering, procurement, fabrication, and construction services related to cryogenic and other specialty tanks and terminals for LNG, NGLs, hydrogen, ammonia, propane, butane, liquid nitrogen/liquid oxygen, and liquid petroleum; and provides plant work, truck and rail loading/offloading facilities, and marine structures, as well as storage tank and terminal maintenance and repair. This segment also manufactures and sells precision engineered specialty tank products, including geodesic domes, aluminum internal floating roofs, floating suction and skimmer systems, roof drain systems, and floating roof seals. Matrix Service Company was founded in 1984 and is headquartered in Tulsa, Oklahoma.
APLT - Applied Therapeutics, Inc. - Stock Price Chart
CompanyApplied Therapeutics, Inc.
Market Cap164.27MEPS (ttm)-1.24
P/E-EPS this Y47.10%
Forward P/E-EPS next Y6.90%
PEG-EPS past 5Y-54.10%
P/S15.35EPS next 5Y-
P/B-EPS Q/Q61.10%
Dividend-Sales Q/Q-
Insider Own2.40%Inst Own57.10%
Insider Trans0.00%Inst Trans-10.70%
Short Float2.58%EarningsAug 10/b
Analyst Recom1.30Target Price7.67
Avg Volume581.81K52W Range0.50 - 2.83
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARCUS JOEL SDirectorSep 15Option Exercise1.0512,37512,994453,414Sep 19 08:08 PM
Shendelman ShoshanaPresident and CEOJan 11Sale0.9115,87014,442751,625Jan 13 04:34 PM
Perfetti RiccardoChief Medical OfficerJan 11Sale0.916,0535,508154,856Jan 13 04:32 PM
Hansard AdamChief Commercial OfficerJan 11Sale0.914,4954,09092,475Jan 13 04:30 PM
Shendelman ShoshanaPresident and CEOOct 14Buy0.6550,00032,250767,495Oct 14 05:41 PM
OPXS - Optex Systems Holdings, Inc - Stock Price Chart
CompanyOptex Systems Holdings, Inc
IndustryAerospace & Defense
Market Cap28.47MEPS (ttm)0.25
P/E17.20EPS this Y-11.70%
Forward P/E-EPS next Y-
PEG-EPS past 5Y34.80%
P/S1.17EPS next 5Y-
P/B2.12EPS Q/Q66.80%
Dividend-Sales Q/Q16.10%
Insider Own1.40%Inst Own15.70%
Insider Trans58.57%Inst Trans-1.49%
Short Float0.24%Earnings-
Analyst Recom-Target Price-
Avg Volume14.33K52W Range2.17 - 4.18
Optex Systems Holdings, Inc. manufactures and sells optical sighting systems and assemblies primarily for the U.S. department of defense, foreign military applications, and commercial markets in the United States. It offers periscopes, such as laser and non-laser protected plastic and glass periscopes, electronic M17 day/thermal periscopes, and vision blocks; sighting systems, including back up sights, digital day and night sighting systems, M36 thermal periscope, unity mirrors, optical weapon system support and maintenance, and commander weapon station sights; howitzers comprising M137 telescope, M187 mount, M119 aiming device, XM10 and aiming circles; and applied optics center consisting of laser interference filter, optical assemblies, laser filter units, day windows, and specialty thin film coatings, as well as other products, such as muzzle reference systems, binoculars, collimators, optical lenses and elements, and windows. The company also provides various periscope configurations, rifle and surveillance sights, and night vision optical assemblies. Its products are installed on various types of U.S. military land vehicles, such as the Abrams, Bradley, and Stryker families of fighting vehicles, as well as light armored and armored security vehicles. The company offers its products directly to the federal government, prime contractors, and foreign governments. Optex Systems Holdings, Inc. was founded in 1987 and is headquartered in Richardson, Texas. Optex Systems Holdings, Inc operates as a subsidiary of Sileas Corporation.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Topline Capital Partners, LP10% OwnerApr 06Buy2.9915,00044,850806,063Apr 07 07:25 PM
Topline Capital Management, LLApr 06Buy2.9915,00044,850806,063Apr 07 07:30 PM
Topline Capital Management, LLApr 05Buy2.962,4007,104791,063Apr 07 07:30 PM
Topline Capital Partners, LP10% OwnerApr 05Buy2.962,4007,104791,063Apr 07 07:25 PM
SUZ - Suzano S.A. - Stock Price Chart
TickerSUZ [NYSE]
CompanySuzano S.A.
IndustryPaper & Paper Products
Market Cap15.14BEPS (ttm)3.53
P/E3.20EPS this Y-46.20%
Forward P/E7.15EPS next Y-13.70%
PEG0.31EPS past 5Y-
P/S-EPS next 5Y10.30%
P/B-EPS Q/Q2788.60%
Dividend4.22%Sales Q/Q-20.50%
Insider Own-Inst Own2.73%
Insider Trans-Inst Trans-
Short Float0.10%EarningsAug 02/b
Analyst Recom2.00Target Price11.25
Avg Volume1.25M52W Range7.46 - 11.27
Suzano S.A. produces and sells eucalyptus pulp and paper products in Brazil and internationally. It operates through Pulp and Paper segments. The company offers coated and uncoated printing and writing papers, paperboards, tissue papers, and market and fluff pulps; and lignin. It also engages in the research, development, and production of biofuel; operation of port terminals; power generation and distribution business; commercialization of equipment and parts; industrialization, commercialization, and exporting of pulp and standing wood; road freight transport; biotechnology research and development; and commercialization of paper and computer materials. In addition, the company is involved in the business office, production packaging, and financial fundraising activities; research, development, production, commercialization, and distribution of wood-based textile fibers, yarns, and filaments produced from cellulose and microfibrillated cellulose; and research and development of wood raw materials for the textile industry. Suzano S.A. was formerly known as Suzano Papel e Celulose S.A. and changed its name to Suzano S.A. in April 2019. The company was founded in 1924 and is headquartered in Salvador, Brazil.
VLO - Valero Energy Corporation - Stock Price Chart
TickerVLO [NYSE, S&P 500]
CompanyValero Energy Corporation
IndustryOil & Gas Refining & Marketing
Market Cap52.48BEPS (ttm)29.03
P/E5.04EPS this Y-15.80%
Forward P/E10.37EPS next Y-42.55%
PEG-EPS past 5Y42.50%
P/S0.33EPS next 5Y-
P/B2.03EPS Q/Q-53.20%
Dividend2.79%Sales Q/Q-33.20%
Insider Own0.20%Inst Own82.50%
Insider Trans-9.53%Inst Trans-1.47%
Short Float2.81%EarningsJul 27/b
Analyst Recom2.00Target Price149.87
Avg Volume3.64M52W Range97.73 - 150.39
Valero Energy Corporation manufactures, markets, and sells transportation fuels and petrochemical products in the United States, Canada, the United Kingdom, Ireland, Latin America, and internationally. It operates through three segments: Refining, Renewable Diesel, and Ethanol. The company produces California Reformulated Gasoline Blendstock for Oxygenate Blending and Conventional Blendstock for Oxygenate Blending gasolines, CARB diesel, diesel, jet fuel, and asphalt; aromatics; and sulfur crude oils. It sells its refined products through wholesale rack and bulk markets; and through approximately outlets under the Valero, Beacon, Diamond Shamrock, Shamrock, Ultramar, and Texaco brands. The company also produces and sells ethanol, dry distiller grains, syrup, and inedible corn oil primarily to animal feed customers. In addition, it owns and operates crude oil and refined petroleum products pipelines, terminals, tanks, marine docks, truck rack bays, and other logistics assets; and owns and operates a plant that processes animal fats, used cooking oils, and inedible distillers corn oils. The company was formerly known as Valero Refining and Marketing Company and changed its name to Valero Energy Corporation in August 1997. Valero Energy Corporation was founded in 1980 and is headquartered in San Antonio, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gorder Joseph WDirectorAug 14Option Exercise44.8275,5803,387,790697,452Aug 16 04:44 PM
Gorder Joseph WDirectorAug 14Sale135.9975,58010,278,389621,872Aug 16 04:44 PM
Nickles Donald LDirectorApr 28Option Exercise0.001,920031,602May 02 05:27 PM
PROFUSEK ROBERTDirectorApr 28Option Exercise0.001,920043,098May 02 05:32 PM
WILKINS RAYFORD JRDirectorApr 28Option Exercise0.002,378038,895May 02 05:35 PM
HURN - Huron Consulting Group Inc. - Stock Price Chart
CompanyHuron Consulting Group Inc.
IndustryConsulting Services
Market Cap2.05BEPS (ttm)3.65
P/E29.03EPS this Y26.10%
Forward P/E20.87EPS next Y12.34%
PEG2.15EPS past 5Y19.90%
P/S1.58EPS next 5Y13.50%
P/B3.64EPS Q/Q91.60%
Dividend-Sales Q/Q26.40%
Insider Own1.10%Inst Own97.60%
Insider Trans-3.04%Inst Trans-7.54%
Short Float0.94%EarningsJul 27/a
Analyst Recom1.50Target Price111.67
Avg Volume121.26K52W Range64.67 - 106.20
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; financial advisory; software products; and digital solutions, spanning technology and analytic-related services to national and regional health systems, academic and community health systems, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment provides research enterprise, and student and alumni lifecycle; digital solutions, spanning technology, and analytic-related services; Huron Research Suite, a software suite designed to facilitate and enhance research administration service delivery and compliance; and organizational transformation services to public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment delivers digital services and software products, and financial advisory services to financial, energy and utilities, professional and business services, life science, consumer products, and industrials and manufacturing industries, as well as public sector and nonprofit organizations. The company was incorporated in 2002 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roth James HDirectorSep 01Sale100.072,000200,14080,331Sep 06 11:43 AM
Roth James HDirectorAug 17Sale99.272,000198,54082,331Aug 21 11:31 AM
LOCKHART H EUGENEDirectorAug 14Sale99.152,100208,21633,097Aug 16 11:01 AM
Zumwalt DebraDirectorAug 10Sale98.1525925,42125,480Aug 14 09:34 AM
Singh-Bushell EktaDirectorAug 08Sale100.6919219,33219,377Aug 10 09:42 AM
LOCC - Live Oak Crestview Climate Acquisition Corp. - Stock Price Chart
CompanyLive Oak Crestview Climate Acquisition Corp.
IndustryShell Companies
Market Cap260.54MEPS (ttm)0.18
P/E58.93EPS this Y50.30%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.32EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own80.10%
Insider Trans-Inst Trans-4.45%
Short Float0.01%Earnings-
Analyst Recom-Target Price-
Avg Volume372.27K52W Range9.66 - 10.63
Live Oak Crestview Climate Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Live Oak Crestview Climate Acquisition Corp. was incorporated in 2021 and is based in Memphis, Tennessee.